Ajax-Loading

Nxera Pharma Co., Ltd. - Cash Conversion Cycle

Nxera Pharma Co., Ltd.'s Fiscal Year is From January To December - All Figures are in Days.

The item "Cash-Conversion-Cycle" stands at 398.01 days as of 09/30/2025, the highest value at least since 03/31/2024, the period currently displayed.

As of the end of Nxera Pharma Co., Ltd.'s third quarter, the item "Cash Conversion Cycle" stands at 398.01 Days. This represents an increase of 40.81 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 417.36 compared to the value the year prior.
The Serie's long term average value is 186.22 days. It's latest available value, on 09/30/2025, is 211.79 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is +417.36 .
The Serie's change from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 .

Cash Conversion Cycle for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash Conversion Cycle905,699,262,464.00
LogoJohnson & Johnson - Cash Conversion Cycle486,508,953,600.00
LogoAbbVie Inc - Cash Conversion Cycle399,570,305,024.00
LogoRoche Holding AG - Cash Conversion Cycle317,433,206,677.55
LogoAstraZeneca PLC - Cash Conversion Cycle280,205,508,085.11